Procter & Gamble Health Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of P & G Health Ltd With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

370.45

605.74

-235.29

-38.84%

Other Operating Income

0.00

Total Operating income

370.45

605.74

-235.29

-38.84%

Raw Material Cost

85.19

297.46

-212.27

-71.36%

Purchase of Finished goods

22.31

15.89

6.42

40.40%

(Increase) / Decrease In Stocks

-14.63

0.11

-14.74

-13,400.00%

Employee Cost

50.86

95.94

-45.08

-46.99%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

91.13

121.95

-30.82

-25.27%

Total Expenditure (Excl Depreciation)

234.86

531.35

-296.49

-55.80%

Operating Profit (PBDIT) excl Other Income

135.59

74.39

61.20

82.27%

Other Income

4.00

3.97

0.03

0.76%

Operating Profit (PBDIT)

139.59

78.36

61.23

78.14%

Interest

0.21

26.66

-26.45

-99.21%

Exceptional Items

0.00

Gross Profit (PBDT)

139.38

51.70

87.68

169.59%

Depreciation

6.17

25.19

-19.02

-75.51%

Profit Before Tax

133.21

26.51

106.70

402.49%

Tax

38.61

10.16

28.45

280.02%

Provisions and contingencies

0.00

Profit After Tax

94.60

16.35

78.25

478.59%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

94.60

16.35

78.25

478.59%

Equity Capital

16.60

92.17

-75.57

-81.99%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

56.99

1.77

55.22

3,119.77%

Diluted Earnings per share

56.99

1.77

55.22

3,119.77%

Operating Profit Margin (Excl OI)

36.60%

12.28%

0.00

24.32%

Gross Profit Margin

37.62%

8.54%

0.00

29.08%

PAT Margin

25.54%

2.70%

0.00

22.84%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 370.45 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -0.91% vs 15.06% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 19.12% vs 23.17% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 94.60 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 21.92% vs -12.37% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 54.63% vs 31.40% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 135.59 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 22.75% vs -8.16% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 67.56% vs 19.99% in Mar 2025

Quarterly - Interest

Interest 0.21 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 110.00% vs -16.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 61.54% vs -13.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 36.60%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025